TC Biopharm () (TCBPW)
0.01
0.00 (66.67%)
At close: Mar 21, 2025, 3:32 PM
66.67% (1D)
| Bid | n/a |
| Market Cap | 602.6K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.754 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 452,611 |
| Avg. Volume (20D) | 43,683.899 |
| Open | 0.01 |
| Previous Close | 0.01 |
| Day's Range | 0.01 - 0.01 |
| 52-Week Range | 0.01 - 0.01 |
| Beta | 0.01 |
About TCBPW
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR ...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 41
Stock Exchange NASDAQ
Ticker Symbol TCBPW
Website https://www.tcbiopharm.com